Reynolds, Andrew R.
AstraZeneca,
United Kingdom
2025 Rank: 183258
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 5639 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 183258 | 198337 |
| Total Cites | 494 | 542 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 27 | 29 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 215 | 225 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 395 | 420 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.29 |
| Self-Citation Percentage |
8.86%
|
|
Reynolds, Andrew R.
AstraZeneca,
United Kingdom
2023 Rank: 127196
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4508 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127196 | 136392 |
| Total Cites | 641 | 716 |
| H-index | 12 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 26 | 26 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 279 | 301 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 507 | 547 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
10.47%
|
|
Reynolds, Andrew R.
AstraZeneca,
United Kingdom
2022 Rank: 132653
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4988 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 132653 | 142206 |
| Total Cites | 538 | 606 |
| H-index | 12 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 35 | 37 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 237 | 257 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 451 | 484 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.25 |
| Self-Citation Percentage |
11.22%
|
|
Reynolds, Andrew R.
AstraZeneca,
United Kingdom
2021 Rank: 119535
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4253 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119535 | 130129 |
| Total Cites | 833 | 958 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 46 | 48 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 359 | 396 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 698 | 760 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.26 |
| Self-Citation Percentage |
13.05%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.